Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Shiran Ferber"'
Autor:
Pere Dosta, Alexander M. Cryer, Michaela Prado, Michelle Z. Dion, Shiran Ferber, Santhosh Kalash, Natalie Artzi
Publikováno v:
Advanced NanoBiomed Research, Vol 1, Iss 7, Pp n/a-n/a (2021)
The activation of stimulator of interferon genes (STING) in the cytosol by cyclic dinucleotides (CDNs) enhances antitumor immunity through the induction of proinflammatory cytokines, such as type‐I interferons (IFN‐I). However, the high hydrophil
Externí odkaz:
https://doaj.org/article/b97991a6ce664800aac892568aa765f8
Autor:
Shiran Ferber, Galia Tiram, Ana Sousa-Herves, Anat Eldar-Boock, Adva Krivitsky, Anna Scomparin, Eilam Yeini, Paula Ofek, Dikla Ben-Shushan, Laura Isabel Vossen, Kai Licha, Rachel Grossman, Zvi Ram, Jack Henkin, Eytan Ruppin, Noam Auslander, Rainer Haag, Marcelo Calderón, Ronit Satchi-Fainaro
Publikováno v:
eLife, Vol 6 (2017)
Glioblastoma is a highly aggressive brain tumor. Current standard-of-care results in a marginal therapeutic outcome, partly due to acquirement of resistance and insufficient blood-brain barrier (BBB) penetration of chemotherapeutics. To circumvent th
Externí odkaz:
https://doaj.org/article/0eee86515bdb4c6ea5b82391574a5267
Autor:
Ronit Satchi-Fainaro, Shiran Ferber, Ehud Segal, Lili Ma, Niharika Dixit, Ambreen Ijaz, Lynn Hlatky, Amir Abdollahi, Nava Almog
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e44395 (2012)
Although dormant tumors are highly prevalent within the human population, the underlying mechanisms are still mostly unknown. We have previously identified the consensus gene expression pattern of dormant tumors. Here, we show that this gene expressi
Externí odkaz:
https://doaj.org/article/832447a2bae541d5bb39359634f92912
Autor:
Pere Dosta, Alexander M. Cryer, Michelle Z. Dion, Tsubasa Shiraishi, Steven P. Langston, David Lok, Jianing Wang, Sean Harrison, Shiran Ferber, Santhosh Kalash, Michaela Prado, Alma L. Rodríguez, Adnan O. Abu-Yousif, Natalie Artzi
Stimulator of interferon genes (STING) agonist is a promising activator of antitumor immunity. However, the systemic delivery of STING agonist, based on cyclic dinucleotides (CDNs), yields limited anticancer activity owing to poor serum stability and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c600aad6a1daa959876f75ce8524808a
https://doi.org/10.21203/rs.3.rs-1647238/v1
https://doi.org/10.21203/rs.3.rs-1647238/v1
Autor:
Michelle Z. Dion, Shiran Ferber, Natalie Artzi, Michaela Prado, Santhosh Kalash, Pere Dosta, Alexander M. Cryer
Publikováno v:
Advanced NanoBiomed Research, Vol 1, Iss 7, Pp n/a-n/a (2021)
The activation of stimulator of interferon genes (STING) in the cytosol by cyclic dinucleotides (CDNs) enhances antitumor immunity through the induction of proinflammatory cytokines, such as type‐I interferons (IFN‐I). However, the high hydrophil
Autor:
Zvi Ram, Roni Blatt, Marcelo Calderón, Adva Krivitsky, Eylon Yavin, Rachel Grossman, Galia Tiram, Eytan Ruppin, Eilam Yeini, Orit Amsalem, Michael Milyavsky, Anat Eldar-Boock, Joo Sang Lee, Philip Lazarovici, Shiran Ferber, Jack Henkin, Rainer Haag, Dikla Ben-Shushan, Paula Ofek, Ronit Satchi-Fainaro, Nava Almog, Gadi Cohen
Publikováno v:
The FASEB Journal. 32:5835-5850
Glioblastoma is an aggressive and invasive brain malignancy with high mortality rates despite current treatment modalities. In this study, we show that a 7-gene signature, previously found to govern the switch of glioblastomas from dormancy to aggres
Autor:
Pere Dosta, Yi Zhang, Kui Wang, Nicholas Uth, Eytan Abraham, Shiran Ferber, Albert Ros, Natalie Artzi, Yonatan Levinson
Publikováno v:
Journal of biomedical materials research. Part B, Applied biomaterialsREFERENCES. 108(7)
Microcarriers, including crosslinked porous gelatin beads (Cultispher G) are widely used as cell carriers for cell therapy applications. Microcarriers can support a range of adherent cell types in stirred tank bioreactor culture, which is scalable up
Autor:
Rony Shreberk-Hassidim, Paula Ofek, Rainer Haag, Noam Shomron, Galia Tiram, Marcelo Calderón, Sarit Aviel-Ronen, Taturo Udagawa, Batsheva Kerem, Shiran Ferber, Yuval Shaked, Iris Barshack, Ehud Segal, Liat Edry, Maayan Roniger, Ronit Satchi-Fainaro, Adva Krivitsky
Publikováno v:
ACS Nano. 10:2028-2045
The presence of dormant, microscopic cancerous lesions poses a major obstacle for the treatment of metastatic and recurrent cancers. While it is well-established that microRNAs play a major role in tumorigenesis, their involvement in tumor dormancy h
Autor:
Noga Yerushalmi, Shiran Ferber, Paula Ofek, Adva Krivitsky, Galia Tiram, Marcelo Calderón, Ronit Satchi-Fainaro, Rachel Grossman, Fatemeh Sheikhi Mehrabadi, Zvi Ram, Rainer Haag, Sharon Kredo-Russo
Publikováno v:
Nanomedicine
Glioblastoma multiforme (GBM) is the most common and aggressive primary neoplasm of the brain. Poor prognosis is mainly attributed to tumor heterogeneity, invasiveness, and drug resistance. microRNA-based therapeutics represent a promising approach d
Autor:
Alexander M. Cryer, Betty Tyler, Noah Gorelick, Shiran Ferber, Natalie Artzi, Robert Langer, Henry Brem
Publikováno v:
Cancer Immunology Research. 8:A27-A27
Gliomas are the most common solid tumors and the greatest cause of cancer-related deaths among children in the U.S. Treatment for this group of heterogeneous malignancies involves surgery and chemotherapy; however, tumor recurrence is inevitable. Imm